Drugs Made In Stock Volatility
| DMAA Stock | 10.52 0.05 0.48% |
Drugs Made In continues to exhibit relatively low price volatility over the last 3 months. The current Sharpe ratio for Drugs Made In is 0.18, indicating risk-adjusted returns over the last 3 months. 29 technical indicators currently contribute to the broader risk narrative.
Sharpe Ratio = 0.1779
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DMAA |
Drugs Made In reported a Market Risk Adjusted Performance of 0.5%, a Risk of 0.14, and a Risk Adjusted Performance of 0.1%. Based on monthly moving average positioning, Drugs Made is operating near 14% of its observed historical performance range. In portfolio analysis, diversification may alter its risk-adjusted contribution.
Key indicators related to Drugs Made's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Drugs Made Stock volatility depicts how high the prices fluctuate around the mean price. Higher volatility implies greater uncertainty about Drugs Made's future price, while lower volatility suggests more predictable behavior.
Volatility Strategy
Drugs Made In price volatility may influence cost basis positioning and portfolio weighting over time. Price retracements and recoveries can alter allocation balance. Current statistical measures show total volatility near 0.14% with a beta coefficient of 0.0289, indicating sensitivity relative to the broader market benchmark. Risk-adjusted efficiency, represented by a Sharpe ratio of 0.18, evaluates return per unit of total risk. An alpha value of 0.0162 reflects performance relative to systematic market exposure. Expected return estimates near 0.0252% are derived from historical distribution modeling and help frame forward-looking return assumptions within a portfolio context. Macro developments can affect sector-level volatility.
Main indicators related to Drugs Made's market risk premium analysis include:
Beta 0.0289 | Alpha 0.0162 | Risk 0.14 | Sharpe Ratio 0.18 | Expected Return 0.0252 |
Moving together with Drugs Stock
| 0.69 | FGMC | FG Merger II | PairCorr |
| 0.82 | IPCX | Inflection Point | PairCorr |
| 0.89 | IPOD | Dune Acquisition | PairCorr |
| 0.87 | LOKV | Live Oak Acquisition | PairCorr |
| 0.91 | PGAC | Pantages Capital Symbol Change | PairCorr |
| 0.94 | QSEA | Quartzsea Acquisition | PairCorr |
| 0.89 | QUMS | Quantumsphere Acquisition | PairCorr |
| 0.67 | RDAG | Republic Digital | PairCorr |
| 0.89 | SIMA | SIM Acquisition Corp | PairCorr |
| 0.93 | SPEG | Silver Pegasus | PairCorr |
| 0.9 | CHAR | Charlton Aria Acquisition | PairCorr |
| 0.74 | VLGEA | Village Super Market | PairCorr |
Moving against Drugs Stock
Sensitivity To Market
Drugs Made beta coefficient measures the volatility of Drugs stock relative to the systematic risk of the overall market benchmark. Mathematically, beta represents the slope of the regression line comparing Drugs returns against market returns. A beta of 0.0289 indicates the degree of sensitivity to market-wide movements. Current total volatility is approximately 0.14%.Drugs Made In has shown noticeable price swings over the selected period. Downside deviation is about 0.24% and standard deviation is about 0.14%, which summarize how widely returns have moved. For stocks, measured downside deviation helps describe the intensity of negative return periods.
3 Months Beta |Analyze Drugs Made In Demand TrendCheck current 90 days Drugs Made correlation with market (Dow Jones Industrial)Downside Risk
Drugs standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. High standard deviation indicates a volatile instrument; low standard deviation indicates a more stable one.
Standard Deviation | 0.14 |
It is essential to understand the difference between upside risk and downside risk for Drugs Made. Standard deviation measures total volatility including favorable moves, while downside deviation isolates the loss risk in Drugs Made's daily returns. Drugs Made In reported a Downside Deviation of 0.24, a Downside Variance of 0.06, and a Maximum Drawdown of 0.67.
Stock Volatility Analysis
Volatility refers to the frequency at which Drugs Made stock price increases or decreases within a specified period. It is generally measured from either the standard deviation or variance between returns from that same stock.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. Drugs Made In Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Projected Return Density Against Market
Given the investment horizon of 90 days Drugs Made has a beta of 0.0289 suggesting as returns on the market go up, Drugs Made's average returns are expected to increase less than the benchmark. However, during a bear market, the loss from holding Drugs Made In is expected to be smaller as well.Drugs Made is exposed to both systematic and unsystematic risk. Systematic risk reflects broader stock market movements, while company or sector-specific developments represent nonmarket drivers. Diversification may reduce specific risk, but market exposure remains. Beta and standard deviation help quantify volatility. Drugs Made In reported a Downside Deviation of 0.24, a Mean Deviation of 0.09, and a Standard Deviation of 0.14.
Predicted Return Density |
| Returns |
What Drives Drugs Made's Price Volatility?
Several factors can influence Drugs Made's market volatility:Industry Dynamics
Sector-level events can directly affect Drugs Made's price stability. Regulatory changes, supply disruptions, or shifts in demand within Drugs Made's industry may create volatility even when the broader market is calm. Competitive dynamics and industry consolidation can also amplify price swings for companies like Drugs Made.Political and Economic Environment
Macroeconomic conditions and policy decisions shape the backdrop for Drugs Made's price movements. Interest rate changes, trade policy shifts, and fiscal legislation can all alter investor sentiment toward Drugs Made. During periods of economic expansion, Drugs Made's price tends to benefit from broader market optimism, while downturns can amplify selling pressure.Drugs Made's Company-Specific Factors
Volatility can also stem from events unique to Drugs Made. Earnings surprises, management changes, product launches, or legal developments may trigger sharp price reactions in Drugs Made's stock. Conversely, operational setbacks, guidance revisions, or data breaches can weigh on Drugs Made's share price.Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Drugs Made is 562.04. The daily returns are distributed with a variance of 0.02 and standard deviation of 0.14. The mean deviation of Drugs Made In is currently at 0.1. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.8
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | 0.82 |
Stock Return Volatility
Drugs Made historical daily return volatility represents how much of Drugs Made stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company reported 0.1418% volatility on return distribution over a 90-day investment horizon. By contrast, Dow Jones Industrial has volatility of 0.8242% on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Drugs Stock performing well and Drugs Made Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Drugs Made's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SIMA | 0.14 | 0.01 | 0.28 | -0.44 | 0.14 | 0.28 | 2.34 | |||
| MLAC | 0.07 | 0.01 | 0.72 | 0.33 | 0.00 | 0.19 | 0.48 | |||
| TACOU | 0.09 | 0.00 | 0.28 | -0.20 | 0.12 | 0.29 | 1.07 | |||
| ALF | 0.11 | 0.01 | 0.45 | -0.77 | 0.00 | 0.28 | 1.03 | |||
| TACO | 0.09 | 0.00 | 0.54 | -0.02 | 0.04 | 0.20 | 0.78 | |||
| LOKV | 0.06 | 0.00 | 0.73 | 0.10 | 0.00 | 0.10 | 0.58 | |||
| TACH | 0.12 | -0.02 | 0.00 | 0.17 | 0.00 | 0.29 | 0.88 | |||
| OYSE | 0.09 | 0.00 | 0.22 | 0.04 | 0.11 | 0.29 | 1.67 | |||
| RTAC | 0.45 | -0.01 | 0.00 | -0.14 | 0.00 | 1.33 | 3.28 |
Risk Metrics, Assumptions & Methodology
Volatility for Drugs Made measures return dispersion and uncertainty over time. Higher dispersion implies wider price swings across observed periods. Drugs Made has a market cap of 352.6 M.
Unless otherwise specified, data for Drugs Made In is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Volatility and downside metrics are estimated from historical return dispersion.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardDrugs Made Investment Opportunity
Measured over the selected horizon, Dow Jones Industrial carries roughly 5.86 times the return volatility of Drugs Made In. Across the current 90-day horizon, that places the security below 1% of the broader equity and portfolio universe on a pure volatility basis.You can use Drugs Made In to enhance the returns of the portfolio. This directional read frames the latest price swing through a simple momentum and follow-through lens. It works best as a directional cue rather than as a standalone forecast. a normal upward fluctuation. Check odds of Drugs Made to be traded at 11.05 in 90 days.Strong inverse diversification
Drugs Made currently posts a -0.29 correlation with Dow Jones, indicating a Strong inverse diversification relationship for the active sample. The overlap area shows the portion of risk that can be diversified away by holding both instruments together.
Drugs Made Additional Risk Indicators
Looking at additional risk metrics for Drugs Made In frames how the position may behave under different market and portfolio conditions. The practical goal is to identify how much risk is being accepted and whether that risk still fits the thesis.
| Risk Adjusted Performance | 0.0883 | |||
| Market Risk Adjusted Performance | 0.4707 | |||
| Mean Deviation | 0.0927 | |||
| Downside Deviation | 0.2383 | |||
| Coefficient Of Variation | 584.98 | |||
| Standard Deviation | 0.1364 | |||
| Variance | 0.0186 |
Drugs Made Suggested Diversification Pairs
Pair trading with Drugs Made can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The advantage is that adverse movement in one leg may be partly offset by the other when correlation and thesis alignment hold.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Drugs Made as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Drugs Made's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Drugs Made's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Drugs Made In.
Popular Tools for Drugs Stock analysis
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |